Audentes Therapeutics
Audentes Therapeutics is a Genetic Medicines company. The company overall incidence is estimated to be approximately 1 in 40,000 births although frequency and disease progression varies with age of onset, ethnicity and geography. The headquarters is in USA.
Astellas completes acquision of Audentes in Jan 2020 for approximately 3 Billion USD.